Fujita Masaki, Ishibashi Tsuneo, Hara Nobuyuki, Yoshida Minoru, Yamada Hozumi
Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu Univiersity.
Jpn J Antibiot. 2003 Aug;56(4):289-93.
To verify the indication of intravenous fluoroquinolone in guideline for treatment of community-acquired pneumonia published in Japanese Respiratory Society, the effect of intravenous ciprofloxacin was investigated in this study. 49 cases of community-acquired pneumonia were treated by intravenous ciprofloxacin. Total response rate was 77.1%. 66.7% of response rate was achieved even in the cases which other antibiotics had been already introduced and failed. The data of this study indicated that intravenous ciprofloxacin was one of the effective and appropriate therapeutics for community-acquired pneumonia in adults.
为验证日本呼吸学会发布的社区获得性肺炎治疗指南中静脉使用氟喹诺酮类药物的适应证，本研究调查了静脉使用环丙沙星的疗效。49例社区获得性肺炎患者接受了静脉环丙沙星治疗。总有效率为77.1%。即使在已使用其他抗生素但治疗失败的病例中，有效率仍达到66.7%。本研究数据表明，静脉使用环丙沙星是治疗成人社区获得性肺炎的有效且合适的疗法之一。
